JP2023517035A5 - - Google Patents

Info

Publication number
JP2023517035A5
JP2023517035A5 JP2022553155A JP2022553155A JP2023517035A5 JP 2023517035 A5 JP2023517035 A5 JP 2023517035A5 JP 2022553155 A JP2022553155 A JP 2022553155A JP 2022553155 A JP2022553155 A JP 2022553155A JP 2023517035 A5 JP2023517035 A5 JP 2023517035A5
Authority
JP
Japan
Prior art keywords
composition
use according
subject
cells
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022553155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517035A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/055483 external-priority patent/WO2021176001A1/en
Publication of JP2023517035A publication Critical patent/JP2023517035A/ja
Publication of JP2023517035A5 publication Critical patent/JP2023517035A5/ja
Pending legal-status Critical Current

Links

JP2022553155A 2020-03-05 2021-03-04 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 Pending JP2023517035A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020900685 2020-03-05
AU2020900685A AU2020900685A0 (en) 2020-03-05 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
PCT/EP2021/055483 WO2021176001A1 (en) 2020-03-05 2021-03-04 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells

Publications (2)

Publication Number Publication Date
JP2023517035A JP2023517035A (ja) 2023-04-21
JP2023517035A5 true JP2023517035A5 (cg-RX-API-DMAC7.html) 2024-03-13

Family

ID=74867509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022553155A Pending JP2023517035A (ja) 2020-03-05 2021-03-04 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法

Country Status (9)

Country Link
US (1) US12697355B2 (cg-RX-API-DMAC7.html)
EP (1) EP4114418B1 (cg-RX-API-DMAC7.html)
JP (1) JP2023517035A (cg-RX-API-DMAC7.html)
KR (1) KR20220150919A (cg-RX-API-DMAC7.html)
CN (1) CN115361958A (cg-RX-API-DMAC7.html)
AU (1) AU2021232614A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022017557A2 (cg-RX-API-DMAC7.html)
CA (1) CA3170255A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021176001A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
WO2021176001A1 (en) 2020-03-05 2021-09-10 Mesoblast International Sàrl Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
EP4181935A1 (en) * 2020-07-20 2023-05-24 Brainstorm Cell Therapeutics Ltd. Methods and compositions for treating lung conditions

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US6974571B2 (en) 1995-03-28 2005-12-13 Thomas Jefferson University Isolated stromal cells and methods of using the same
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US20030103951A1 (en) 1997-07-14 2003-06-05 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
WO1999003973A1 (en) 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
DE69922933T2 (de) 1998-03-13 2005-12-29 Osiris Therapeutics, Inc. Anwendungen für humane nicht autologe, mesenchymale stammzellen
WO1999047163A2 (en) 1998-03-18 1999-09-23 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US20030118567A1 (en) 1999-03-26 2003-06-26 Stewart Duncan John Cell-based therapy for the pulmonary system
WO1999051247A1 (en) 1998-04-03 1999-10-14 Osiris Therapeutics, Inc. Use of human mesenchymal stem cells to induce t-cell apoptosis
JP2002510655A (ja) 1998-04-03 2002-04-09 オシリス セラピューティクス,インコーポレイテッド 免疫抑制剤としての間葉幹細胞によるt細胞応答を阻害する方法とその利用
US6030836A (en) 1998-06-08 2000-02-29 Osiris Therapeutics, Inc. Vitro maintenance of hematopoietic stem cells
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
AU7611500A (en) 1999-09-24 2001-04-24 Abt Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6685936B2 (en) 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US6936281B2 (en) 2001-03-21 2005-08-30 University Of South Florida Human mesenchymal progenitor cell
US20030104997A1 (en) 2001-09-05 2003-06-05 Black Ira B. Multi-lineage directed induction of bone marrow stromal cell differentiation
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US7628988B2 (en) 2002-06-27 2009-12-08 The General Hospital Corporation Methods and compositions for treating type 1 diabetes
EP1551955A4 (en) 2002-07-16 2006-11-29 Yissum Res Dev Co METHOD FOR IMPLANTING MESENCHYMAL STEM CELLS FOR TISSUE PAIRING AND FORMATION
WO2004009767A2 (en) 2002-07-23 2004-01-29 Boston Scientific Limited Cell therapy for regeneration
US20060210544A1 (en) 2003-06-27 2006-09-21 Renomedix Institute, Inc. Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CA2564679C (en) 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
ES2385450T3 (es) 2004-03-22 2012-07-25 Osiris Therapeutics, Inc. Células madre mesenquimatosas y sus utilizaciones
JP5162756B2 (ja) 2005-04-14 2013-03-13 財団法人ヒューマンサイエンス振興財団 医薬組成物及びその製造方法
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
US20070253931A1 (en) 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
CN101370930A (zh) 2006-01-13 2009-02-18 奥西里斯治疗公司 表达TNF-α受体的间充质干细胞
EP2057195A4 (en) 2006-08-29 2010-05-12 Forhumantech Co Ltd PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
EP2578677A1 (en) 2007-08-09 2013-04-10 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
KR101039235B1 (ko) 2007-08-29 2011-06-07 메디포스트(주) 제대혈 유래 간엽줄기세포를 포함하는 인터루킨-8 또는지알오-알파 발현 세포가 관련된 질병의 진단, 예방 또는치료용 조성물
KR101995016B1 (ko) 2007-12-04 2019-06-28 프로테오바이오엑티브스 피티와이 엘티디 전구 세포의 보호 및 그의 분화 조절
WO2009154840A2 (en) 2008-03-27 2009-12-23 Neostem, Inc. Compositions and methods using stem cells in cutaneous wound healing
MX2011001730A (es) 2008-08-14 2011-03-24 Osiris Therapeutics Inc Composiciones purificadas de celulas madre mesenquimales y metodos para purificar composiciones de celulas madre mesenquimales.
WO2011047345A2 (en) 2009-10-15 2011-04-21 Tai June Yoo Methods of treating diseases of conditions using mesenchymal stem cells
KR101871472B1 (ko) 2010-07-02 2018-06-27 메소블라스트, 아이엔씨. 이식편대숙주 질환의 치료 방법
CA2809272A1 (en) 2010-08-31 2012-03-08 Cook General Biotechnology Llc Systemic, allogenic stem cell therapies for treatment of diseases in animals
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
EP2714057B1 (en) 2011-06-03 2019-11-06 Mesoblast, Inc. Methods of treating or preventing neurological diseases
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
US20160199413A1 (en) * 2013-08-01 2016-07-14 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
JP6173157B2 (ja) 2013-10-02 2017-08-02 日本製薬株式会社 Il−17産生抑制組成物
WO2015061839A1 (en) 2013-11-04 2015-05-07 Sturm Marian June Cell culture method
CN114317461A (zh) 2013-11-22 2022-04-12 德那翠丝有限公司 表达免疫细胞刺激受体激动剂的腺病毒
KR102577698B1 (ko) 2014-04-07 2023-09-12 메조블라스트 인터내셔널 에스에이알엘 개선된 줄기 세포 조성물
WO2015189063A1 (en) 2014-06-10 2015-12-17 Mesoblast International Sàrl Treatment of immune disorders
WO2016086020A1 (en) 2014-11-24 2016-06-02 Cytostormrx Llc Encapsulated stem cells for the treatment of inflammatory disease
CN107206027A (zh) 2014-12-23 2017-09-26 迈索布拉斯特国际有限公司 进行性心力衰竭的预防
CN105796598A (zh) 2014-12-29 2016-07-27 西比曼生物科技(上海)有限公司 一种用于治疗慢性阻塞性肺疾病的脂肪间充质祖细胞复合物
US20180037867A1 (en) 2015-03-04 2018-02-08 Mesoblast International Sàrl Cell culture method for mesenchymal stem cells
AU2016258980B2 (en) 2015-05-05 2022-02-17 Mesoblast International Sàrl Potency assay
JP7082372B2 (ja) 2017-02-15 2022-06-08 ロート製薬株式会社 肺線維症治療剤、ptprr発現促進剤及び肺線維症治療用キット
EP3619294A1 (en) 2017-05-04 2020-03-11 Mesoblast International Sàrl Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
CL2017002357A1 (es) 2017-09-16 2018-04-20 Cells For Cells S A Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
EP4772245A3 (en) 2019-01-02 2026-08-19 Mesoblast International Sàrl Method for treating lower back pain
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
US20220160776A1 (en) 2019-01-28 2022-05-26 Mesoblast International Sárl Method for treating or preventing gastrointestinal bleeding
CN113853206A (zh) 2019-05-23 2021-12-28 迈索布拉斯特国际有限公司 脑梗塞的功能恢复
EP3994245A1 (en) 2019-07-05 2022-05-11 Case Western Reserve University Priming media and methods for stem cell culture and therapy
KR20220038485A (ko) 2019-08-05 2022-03-28 메조블라스트 인터내셔널 에스에이알엘 바이러스 벡터를 포함하는 세포 조성물 및 치료 방법
KR20220143092A (ko) 2020-02-19 2022-10-24 메조블라스트 인터내셔널 에스에이알엘 만성 이식편 대 숙주 질환의 치료 방법
CN111297899A (zh) * 2020-02-21 2020-06-19 云南雅盛医疗科技有限公司 一种脐带间充质干细胞在制备治疗新型冠状肺炎药物中的应用
WO2021176001A1 (en) 2020-03-05 2021-09-10 Mesoblast International Sàrl Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
CN115297875A (zh) 2020-03-11 2022-11-04 迈索布拉斯特国际有限公司 治疗炎症性肠病的方法ii
BR112022017560A2 (pt) 2020-03-11 2022-12-27 Mesoblast Int Sarl Método para tratar doença inflamatória intestinal i
JP2023520233A (ja) 2020-04-03 2023-05-16 メゾブラスト・インターナショナル・エスアーエールエル 間葉系統前駆細胞又は幹細胞を使用する過炎症の治療方法
JP2023524660A (ja) 2020-04-28 2023-06-13 ファクター バイオサイエンス インコーポレイテッド 間葉系幹細胞療法
CA3181611A1 (en) 2020-06-11 2021-12-16 Paul Simmons 3d culture of mesenchymal lineage precursor or stem cells
US20230398154A1 (en) 2020-08-10 2023-12-14 Mesoblast International Sárl A composition comprising mesenchymal precursor or stem cells and their use
CN115996735A (zh) 2020-08-10 2023-04-21 迈索布拉斯特国际有限公司 细胞组合物和治疗方法
WO2022132986A2 (en) 2020-12-15 2022-06-23 Mesoblast International Sarl Method of treating progressive heart failure in subjects with class ii heart failure
CN112522191B (zh) 2020-12-18 2023-05-12 云南中科灵长类生物医学重点实验室 一种间充质干细胞的培养方法
AU2022210364A1 (en) 2021-01-22 2023-08-31 Mesoblast International Sàrl Opioid sparing compositions and methods of using the same
BR112023021840A2 (pt) 2021-04-23 2024-02-06 Mesoblast Int Sarl Método para tratar síndrome da dificuldade respiratória aguda (ards) com o uso de percursor de linhagem mesenquimal ou células-tronco
AU2022394471A1 (en) 2021-11-17 2024-06-20 Mesoblast International Sarl Method of treating progressive heart failure in subjects at high risk of poor outcomes
US20250032552A1 (en) 2021-12-23 2025-01-30 Mesoblast International Sárl Method of treating severe graft versus host disease
CA3257272A1 (en) 2022-05-26 2023-11-30 Mesoblast International Sàrl HIGH FLOW FILTER AND METHOD OF USE
EP4536253A1 (en) 2022-06-08 2025-04-16 Mesoblast International Sàrl Mesenchymal progenitor cells for enhancing partial reprogramming of target cells

Similar Documents

Publication Publication Date Title
Pickles et al. Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
Petersen et al. Aetiology of biliary atresia: what is actually known?
Ballard-Croft et al. Large-animal models of acute respiratory distress syndrome
Forrester et al. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings
JP2023513847A5 (cg-RX-API-DMAC7.html)
JP2023520233A5 (cg-RX-API-DMAC7.html)
Ackermann Lamb model of respiratory syncytial virus–associated lung disease: insights to pathogenesis and novel treatments
JP7464737B2 (ja) 肺上皮細胞の損傷及び/又は血管内皮細胞の損傷によって媒介される疾患の治療における低分子化合物の用途
WO2014126176A1 (ja) 炎症性疾患の予防又は治療用組成物
Merolla et al. Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta
WO2021016727A1 (zh) 针对纤维化、炎症、和/或老化疾病的治疗药物
JP2023520233A (ja) 間葉系統前駆細胞又は幹細胞を使用する過炎症の治療方法
TW201709915A (zh) 用於治療肝臟疾病的間葉幹細胞
CN111407754A (zh) 卡谷氨酸在制备预防和治疗冠状病毒的药物中的应用
CN115361958A (zh) 使用间充质谱系前体或干细胞治疗炎症性肺病的方法
Tzouvelekis et al. Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect
JP7045670B2 (ja) 多能性幹細胞による虚血再灌流肺障害の軽減及び治療
JP2023519120A (ja) 温度応答型ウイルス貯蔵システム
WO2021213488A1 (zh) 抑制细胞因子风暴的方法及组合物
Ehrsam et al. Lung transplantation in children
WO2022056897A1 (zh) 白细胞介素37与干扰素联用在治疗病毒感染中的应用
Lis et al. Add-on treatment with nebulized hypertonic saline in a child with plastic bronchitis after the Glenn procedure
Distefano et al. Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn
JP2023535298A (ja) 急性呼吸器炎症状態およびサイトカインストーム症候群を処置する方法
Tonazzo et al. Old and emerging therapies for childhood interstitial lung disease (chILD): a systematic review